NCT05714735 (SMCV) is a clinical trial of Cerebral Venography in Arterial Aneurysm, sponsored by Xuanwu Hospital, Beijing.

Who is sponsoring NCT05714735?

NCT05714735 is sponsored by Xuanwu Hospital, Beijing.

What drugs are being tested in NCT05714735?

Interventions in NCT05714735: Cerebral Venography.

What condition does NCT05714735 study?

NCT05714735 studies Arterial Aneurysm.

Is NCT05714735 still recruiting?

NCT05714735 is currently status unknown. Last updated 6 February 2023.

Last reviewed 2023-02-06 · How we verify

NCT05714735: SMCV

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SMCV Assessment on Brain Swelling in Patients With SAH From Ruptured Artery Aneurysm

Status unknown Last updated 6 February 2023

What this trial tests

trial testing Cerebral Venography in Arterial Aneurysm in 198 participants. Status unknown.

Timeline

1 November 2017

Primary endpoint
7 December 2019

30 December 2023

Quick facts

Lead sponsor	Xuanwu Hospital, Beijing
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	198
Start date	1 November 2017
Primary completion	7 December 2019
Estimated completion	30 December 2023
Sites	1 location across China

Drugs / interventions tested

Cerebral Venography

Conditions studied

Arterial Aneurysm — all drugs for Arterial Aneurysm →

Sponsor

Xuanwu Hospital, Beijing

Who can join

Adults 18 to 70, any sex, with Arterial Aneurysm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Superficial cerebral veins findings in assessment of brain swelling in patients with aneurysmal subarachnoid hemorrhage who underwent intravenenous DSA examinations

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Arterial Aneurysm

Currently open trials in the same condition.

NCT07187596 — Mortality Outcome of Controlled Hypertension · active not recruiting
NCT06325371 — Italian Multicentric Study on the Treatment of Visceral Aneurysms With the Flow Diversion Stent Derivo Peripher and Deri · recruiting

Other Xuanwu Hospital, Beijing trials

Trials by the same sponsor.

NCT07095933 — The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy · EARLY_PHASE1 · recruiting
NCT07519044 — Safety and Efficacy of Adjunctive GM1 to Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion · Phase 4 · not yet recruiting
NCT07396077 — Pre-operative Risk Assessment Combined With Targeted Intervention in the Chinese Elderly With Spine Surgery II · NA · not yet recruiting
NCT07457125 — The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease · Phase 1, PHASE2 · not yet recruiting
NCT07479446 — Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05714735 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Xuanwu Hospital, Beijing
Last refreshed: 6 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05714735.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing